Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$786M |
| 2 |
Apple
AAPL
|
+$564M |
| 3 |
Amazon
AMZN
|
+$486M |
| 4 |
Meta Platforms (Facebook)
META
|
+$331M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sherwin-Williams
SHW
|
+$1.88B |
| 2 |
Alibaba
BABA
|
+$1.21B |
| 3 |
Home Depot
HD
|
+$320M |
| 4 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$274M |
| 5 |
FLIR
FLIR Systems, Inc. (DE) Common Stock
FLIR
|
+$135M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.98% |
| 2 | Financials | 13.87% |
| 3 | Healthcare | 13.39% |
| 4 | Consumer Discretionary | 11.81% |
| 5 | Communication Services | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Group 1 Automotive
GPI
$3.42B
| $50.3M | 0.01% |
325,968
+19,185
| +6% | +$3.08M |
|
1302
CNX Resources
CNX
$5.3B
| $50.3M | 0.01% |
3,684,687
+143,663
| +4% | +$2.01M |
|
1303
Vishay Intertechnology
VSH
$5.25B
| $50.3M | 0.01% |
2,231,811
+91,126
| +4% | +$2.19M |
|
1304
Calix
CALX
$2.26B
| $50.3M | 0.01% |
1,058,635
+42,259
| +4% | +$1.86M |
|
1305
Pacira BioSciences
PCRX
$1.04B
| $50.2M | 0.01% |
827,427
+34,365
| +4% | +$2.18M |
|
|
ALLK
1306
DELISTED
Allakos
ALLK
| $50.2M | 0.01% |
587,978
+83,327
| +17% | +$8.32M |
|
1307
Urban Outfitters
URBN
$6.35B
| $50.2M | 0.01% |
1,217,383
+32,082
| +3% | +$1.21M |
|
|
UNVR
1308
DELISTED
Univar Solutions Inc.
UNVR
| $50.1M | 0.01% |
2,056,966
+57,409
| +3% | +$1.44M |
|
1309
ABM Industries
ABM
$2.81B
| $50.1M | 0.01% |
1,130,729
+57,922
| +5% | +$2.91M |
|
1310
Avista
AVA
$3.34B
| $50.1M | 0.01% |
1,173,615
+50,534
| +4% | +$2.32M |
|
1311
Yelp
YELP
$1.45B
| $50.1M | 0.01% |
1,252,744
+26,034
| +2% | +$1.03M |
|
1312
ASML
ASML
$626B
| $50M | 0.01% |
72,332
+1,777
| +3% | +$1.17M |
|
1313
Atlantic Union Bankshares
AUB
$6.02B
| $50M | 0.01% |
1,379,437
+61,264
| +5% | +$2.4M |
|
1314
FormFactor
FORM
$8.28B
| $49.9M | 0.01% |
1,367,967
+41,034
| +3% | +$1.62M |
|
|
UCB
1315
United Community Banks
UCB
$4.24B
| $49.8M | 0.01% |
1,554,665
+140,764
| +10% | +$4.74M |
|
1316
Nu Skin
NUS
$252M
| $49.7M | 0.01% |
877,402
+214,808
| +32% | +$12.2M |
|
1317
MillerKnoll
MLKN
$1.53B
| $49.7M | 0.01% |
1,053,540
-72,726
| -6% | -$3.29M |
|
1318
American States Water
AWR
$3.36B
| $49.5M | 0.01% |
622,489
+17,678
| +3% | +$1.41M |
|
1319
Abercrombie & Fitch
ANF
$4.42B
| $49.4M | 0.01% |
1,064,402
+56,514
| +6% | +$2.28M |
|
|
WBT
1320
DELISTED
Welbilt, Inc.
WBT
| $49.3M | 0.01% |
2,129,358
+32,298
| +2% | +$685K |
|
1321
Allegiant Air
ALGT
$2.64B
| $49.3M | 0.01% |
253,922
+33,254
| +15% | +$7.45M |
|
1322
BioCryst Pharmaceuticals
BCRX
$2.28B
| $49.2M | 0.01% |
3,112,562
+122,039
| +4% | +$1.66M |
|
1323
Mercury Systems
MRCY
$5.83B
| $49.1M | 0.01% |
740,644
+26,581
| +4% | +$1.84M |
|
|
FSR
1324
DELISTED
Fisker Inc.
FSR
| $49.1M | 0.01% |
2,544,292
+1,396,292
| +122% | +$20.6M |
|
|
GRA
1325
DELISTED
W.R. Grace & Co.
GRA
| $49M | 0.01% |
709,116
+4,065
| +0.6% | +$274K |
|
Similar funds
Geode Capital Management's Q2 2021 Portfolio in Review
As of Q2 2021, Geode Capital Management held 4,790 positions worth $726B, up 11% from $654B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Geode Capital Management's Q2 2021 filing shows 331 new, 3,384 increased, 720 reduced and 74 closed positions. Its largest new stake was Organon & Co: 5,070,121 shares worth $153M. The largest sale was Sherwin-Williams, an estimated $1.88B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q2 2021 buy was Organon & Co: 5,070,121 shares worth $153M.
- Geode Capital Management added most to Microsoft in Q2 2021, an estimated $786M increase.
- Geode Capital Management's biggest Q2 2021 reduction was Sherwin-Williams, cutting an estimated $1.88B.
- Geode Capital Management fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $274M.
- Geode Capital Management's ten largest holdings make up 22% of its $726B portfolio in Q2 2021.
- Geode Capital Management opened 331 new positions and closed 74 in Q2 2021.
- Geode Capital Management's portfolio value rose 11% quarter-over-quarter to $726B.
Based on Geode Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.